Adolescent cannabis use: What is the evidence for functional brain alteration?

Current Pharmaceutical Design

Volumn 22, Issue , 2016, Pages

  Lorenzetti, V ^a   Alonso Lana, S ^a,b,c   Youssef, G J ^d   Verdejo Garcia, A ^a   Suo, C ^a   Cousijn, J ^e   Takagi, M ^f   Yucel M ^a   Solowij, N ^g  

^a MONASH UNIVERSITY   (Australia)

^b FIDMAG GERMANES HOSPITALÀRIES RESEARCH FOUNDATION   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^d DEAKIN UNIVERSITY   (Australia)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

^f MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^g UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

Adolescence; Brain; Cannabis; Frontal cortex; Functional neuroimaging; Hyperactivity; Parietal cortex

Indexed keywords

CANNABIS;

ALCOHOL CONSUMPTION; BRAIN FUNCTION; CANNABIS USE; CONFOUNDING VARIABLE; ELECTROENCEPHALOGRAM; EXECUTIVE FUNCTION; FAMILY HISTORY; FRONTAL LOBE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MENTAL DISEASE; MENTAL HEALTH; PARIETAL LOBE; PRIORITY JOURNAL; REVIEW; REWARD; SUBSTANCE USE; TASK PERFORMANCE; TOBACCO USE; WORKING MEMORY; ALCOHOLISM; ATTENTION DEFICIT DISORDER; COMORBIDITY; CONDUCT DISORDER; EMOTIONALITY; FRONTAL CORTEX; FUNCTIONAL NEUROIMAGING; PARIETAL CORTEX; SUBSTANCE ABUSE; ADOLESCENT; BRAIN; CANNABIS ADDICTION; COMPLICATION; METABOLISM; PATHOPHYSIOLOGY;

ADOLESCENT; BRAIN; CANNABIS; HUMANS; MARIJUANA ABUSE;

EID: 85011081950     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612822666160805155922     Document Type: Review

References (106)

1. UNODC. World drug report 2014. In: UNDOC, ededs., World drug report series. United Nations Office on Drugs and Crime 2014.
2. Johnston LD, O’Malley PM, Bachman JG, Schulenberg JE. Monitoring the Future: National Results on Adolescent Drug Use. Overview of Key Findings 2009. NIH Publication No. 10-7583. National Institutes of Health 2010.
3. Squeglia LM, Jacobus J, Tapert SF. The influence of substance use on adolescent brain development. Clin EEG Neurosci 2009; 40: 31-8.
4. Crews F, He J, Hodge C. Adolescent cortical development: a critical period of vulnerability for addiction. Pharmacol Biochem Behavior 2007; 86: 189-99.
5. Schneider M. Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure. Addiction Biol 2008; 13: 253-63.
6. Mechoulam R, Parker LA. The Endocannabinoid System and the Brain. Ann Rev Psychol 2013; 64: 21-47.
7. Mulder J, Aguado T, Keimpema E, et al. Endocannabinoid signaling controls pyramidal cell specification and long-range axon patterning. Proc Natl Acad Sci 2008; 105: 8760-5.
8. Viveros M-P, Llorente R, Suarez J, Llorente-Berzal A, Lopez-Gallardo M, de Fonseca FR. The endocannabinoid system in critical neurodevelopmental periods: sex differences and neuropsychiatric implications. J Psychopharmacol 2012; 26: 164-76.
9. Viveros M-P, Marco E-M, Llorente R, Lopez-Gallardo M. Endocannabinoid system and synaptic plasticity: implications for emotional responses. Neural Plasticity 2007; 2007.
10. Wu CS, Zhu J, Wager-Miller J, et al. Requirement of cannabinoid CB1 receptors in cortical pyramidal neurons for appropriate development of corticothalamic and thalamocortical projections. Eur J Neurosci 2010; 32: 693-706.
11. Mechoulam R, Gaoni Y. Hashish--IV: The isolation and structure of cannabinolic cannabidiolic and cannabigerolic acids. Tetrahedron 1965; 21: 1223-9.
12. Landfield PW, Caldwallader LB, Vinsant S. Quantitative changes in hippocampal structure following long-term exposure to Δ9-tetrahydrocannabinol: possible mediation by glucocorticoid systems. Brain Res 1988; 443: 47-62.
13. Scallet AC. Neurotoxicology of cannabis and THC: A review of chronic exposure studies in animals. Pharmacol Biochem Behavior 1991; 40: 671-6.
14. Tselnicker I, Keren O, Hefetz A, Pick CG, Sarne Y. A single low dose of tetrahydrocannabinol induces long-term cognitive deficits. Neurosci Lett 2007; 411: 108-11.
15. Di Forti M, Morgan C, Dazzan P, et al. High-potency cannabis and the risk of psychosis. Br J Psychiatry 2009; 195: 488-91.
16. Di Forti M, Marconi A, Carra E, et al. Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study. The Lancet Psychiatry 2015; 2: 233-8.
17. Swift W, Wong A, Li KM, Arnold JC, McGregor IS. Analysis of cannabis seizures in NSW, Australia: cannabis potency and cannabinoid profile. PLoS One 2013; 8: e70052.
18. ElSohly MA, Mehmedic Z, Foster S, Gon C, Chandra S, Church JC. Changes in cannabis potency over the last two decades (1995-2014)-Analysis of current data in the united states. Biological Psychiatry 2016.
19. Barnea-Goraly N, Menon V, Eckert M, et al. White matter development during childhood and adolescence: a cross-sectional diffusion tensor imaging study. Cerebral cortex 2005; 15: 1848-54.
20. Gotgay N, Giedd JN, Lusk L, et al. Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci 2004; 101: 8174-9.
21. Huttenlocher PR, Dabholkar AS. Regional differences in synaptogenesis in human cerebral cortex. J Comparat Neurol 1997; 387: 167-78.
22. Rubia K, Overmeyer S, Taylor E, et al. Functional frontalisation with age: mapping neurodevelopmental trajectories with fMRI. Neurosci Biobehav Rev 2000; 24: 13-9.
23. Glass M, Faull RLM, Dragunow M. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 1997; 77: 299.
24. Herkenham M, Lynn AB, Little MD, et al. Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 1990; 87: 1932-6.
25. Haber SN, Knutson B. The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology 2010; 35: 4-26.
26. Dalgleish T. The emotional brain. Nat Rev Neurosci 2004; 5: 583-9.
27. Cabeza R, Nyberg L. Imaging cognition II: An empirical review of 275 PET and fMRI studies. J Cognitive Neurosci 2000; 12: 1-47.
28. Chadwick B, Miller ML, Hurd YL. Cannabis use during adolescent development: susceptibility to psychiatric illness. Frontiers Psychiatry 2013; 4.
29. Copeland J, Rooke S, Swift W. Changes in cannabis use among young people: impact on mental health. Curr Opin Psychiatry 2013; 26: 325-9.
30. Solowij N, Jones KA, Rozman ME, et al. Verbal learning and memory in adolescent cannabis users, alcohol users and non-users. Psychopharmacology (Berl) 2011.
31. Solowij N, Jones KA, Rozman ME, et al. Reflection impulsivity in adolescent cannabis users: a comparison with alcohol-using and non-substance-using adolescents. Psychopharmacology 2012; 219: 575-86.
32. Crane NA, Schuster RM, Fusar-Poli P, Gonzalez R. Effects of cannabis on neurocognitive functioning: recent advances, neurodevelopmental influences, and sex differences. Neuropsychol Rev 2013; 23: 117-37.
33. Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. Br Med J 2002; 325: 1212-3.
34. Fontes MA, Bolla KI, Cunha PJ, et al. Cannabis use before age 15 and subsequent executive functioning. Br J Psychiatry 2011; 198: 442-7.
35. Meier MH, Caspi A, Ambler A, et al. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci USA 2012; 109: E2657-64.
36. Solowij N, Stephens R, Roffman RA, Babor T. Does marijuana use cause long-term cognitive deficits? JAMA 2002; 287: 2653-4; author reply 2654.
37. Rubino T, Parolaro D. Long lasting consequences of cannabis exposure in adolescence. Mol Cell Endocrinol 2008; 286: S108-13.
38. Daniel JZ, Hickman M, Macleod J, et al. Is socioeconomic status in early life associated with drug use? A systematic review of the evidence. Drug Alcohol Rev 2009; 28: 142-53.
39. Verweij KJ, Huizink AC, Agrawal A, Martin NG, Lynskey MT. Is the relationship between early-onset cannabis use and educational attainment causal or due to common liability? Drug Alcohol Dependence 2013; 133: 580-6.
40. Silins E, Horwood LJ, Patton GC, et al. Young adult sequelae of adolescent cannabis use: an integrative analysis. The Lancet Psychiatry 2014; 1: 286-93.
41. Wilkinson ST, Yarnell S, Radhakrishnan R, Ball SA, D’Souza DC. Marijuana Legalization: Impact on Physicians and Public Health. Ann Rev Med 2016; 67: 453-66.
42. Jager G, Ramsey NF. Long-term consequences of adolescent cannabis exposure on the development of cognition, brain structure and function: an overview of animal and human research. Curr Drug Abuse Rev 2008; 1: 114-23.
43. Chang L, Chronicle EP. Functional imaging studies in cannabis users. Neuroscientist 2007; 13: 422-32.
44. Martin-Santos R, Fagundo AB, Crippa JA, et al. Neuroimaging in cannabis use: a systematic review of the literature. Psychol Med 2010; 40: 383-98.
45. Batalla A, Bhattacharyya S, Yucel M, et al. Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings. PLoS One 2013; 8: e55821.
46. Jacobus J, Tapert SF. Effects of Cannabis on the Adolescent Brain. Curr Pharm Des 2014; 20: 2186-93.
47. Behan B, Connolly C, Datwani S, et al. Response inhibition and elevated parietal-cerebellar correlations in chronic adolescent cannabis users. Neuropharmacology 2014; 84: 131-7.
48. De Bellis MD, Wang L, Bergman SR, Yaxley RH, Hooper SR, Huettel SA. Neural mechanisms of risky decision-making and reward response in adolescent onset cannabis use disorder. Drug Alcohol Dependence 2013; 133: 134-45.
49. Jager G, Block RI, Luijten M, Ramsey NF. Tentative evidence for striatal hyperactivity in adolescent cannabis-using boys: a crosssectional multicenter fMRI study. J Psychoactive Drugs 2013; 45: 156-67.
50. Jacobus J, Goldenberg D, Wierenga CE, Tolentino NJ, Liu TT, Tapert SF. Altered cerebral blood flow and neurocognitive correlates in adolescent cannabis users. Psychopharmacology 2012; 222: 675-84.
51. Lopez-Larson MP, Rogowska J, Bogorodzki P, Bueler CE, McGlade EC, Yurgelun-Todd DA. Cortico-cerebellar abnormalities in adolescents with heavy marijuana use. Psychiatry Res: Neuroimaging 2012; 202: 224-32.
52. Schweinsburg AD, Schweinsburg BC, Nagel BJ, Eyler LT, Tapert SF. Neural correlates of verbal learning in adolescent alcohol and marijuana users. Addiction 2011; 106: 564-73.
53. Schweinsburg AD, Schweinsburg BC, Medina KL, McQueeny T, Brown SA, Tapert SF. The influence of recency of use on fMRI response during spatial working memory in adolescent marijuana users. J Psychoactive Drugs 2010; 42: 401-12.
54. Jager G, Block RI, Luijten M, Ramsey NF. Cannabis use and memory brain function in adolescent boys: A cross-sectional multicenter functional magnetic resonance imaging study. J Am Acad Child Adolescent Psychiatry 2010; 49: 561-72.
55. Schweinsburg AD, Nagel BJ, Schweinsburg BC, Park A, Theilmann RJ, Tapert SF. Abstinent adolescent marijuana users show altered fMRI response during spatial working memory. Psychiatry Res: Neuroimag 2008; 163: 40-51.
56. Tapert SF, Schweinsburg AD, Drummond SPA, et al. Functional MRI of inhibitory processing in abstinent adolescent marijuana users. Psychopharmacology 2007; 194: 173-83.
57. Padula CB, Schweinsburg AD, Tapert SF. Spatial Working Memory Performance and fMRI Activation Interactions in Abstinent Adolescent Marijuana Users. Psychol Addictive Behav 2007; 21: 478-87.
58. Schweinsburg AD, Schweinsburg BC, Cheung EH, Brown GG, Brown SA, Tapert SF. fMRI response to spatial working memory in adolescents with comorbid marijuana and alcohol use disorders. Drug Alcohol Dependence 2005; 79: 201-10.
59. Jacobsen LK, Mencl WE, Weterveld M, Pugh KR. Impact of cannabis use on brain function in adolescents. Ann N Y Acad Sci 2004; 1021: 384-90.
60. APA APA. DSM-IV Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition: Washington DC 1996.
61. Kessler RC, Andrews G, Mroczek D, Ustun B, Wittchen HU. The world health organization composite international diagnostic interview short-form (cidi-sf). Int J Methods Psychiatric Res 1998; 7: 171-85.
62. Kaufman J, Birmaher B, Brent D, et al. Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 1997; 36: 980-8.
63. Brown SA, Myers MG, Lippke L, Tapert SF, Stewart DG, Vik PW. Psychometric evaluation of the customary drinking and drug use record (CDDR): A measure of adolescent alcohol and drug involvement. J Studies Alcohol Drugs 1998; 59: 427.
64. Sobell LC, Sobell MB. Timeline Follow-Back: A technique for assessing self-reported alcohol consumption. Humana Press: Totowa NJ 1992.
65. Hibell B, Guttormsson U, Ahlström S, et al. The 2007 ESPAD report. Substance Use Among Students 2009; 35.
66. Skinner HA, Sheu W-J. Reliability of alcohol use indices. The Lifetime Drinking History and the MAST. J Studies On Alcohol 1982; 43: 1157-70.
67. Shaffer D, Fisher P, Lucas CP, Dulcan MK, Schwab-Stone ME. NIMH Diagnostic interview schedule for children version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses. J Am Acad Child Adolescent Psychiatry 2000; 39: 28-38.
68. Lucas CP, Zhang H, Fisher PW, et al. The DISC Predictive Scales (DPS): efficiently screening for diagnoses. J Am Acad Child Adolescent Psychiatry 2001; 40: 443-9.
69. Hall RC. Global assessment of functioning. A modified scale. Psychosomatics 1995; 36: 267-75.
70. Schweinsburg AD, Schweinsburg BC, Medina KL, McQueeny T, Brown SA, Tapert SF. The influence of recency of use on fMRI response during spatial working memory in adolescent marijuana users. J Psychoactive Drugs 2010; 42: 401-12.
71. Baddeley A. Working memory: theories, models, and controversies. Ann Rev psychology 2012; 63: 1-29.
72. Nestor L, Hester R, Garavan H. Increased ventral striatal BOLD activity during non-drug reward anticipation in cannabis users. NeuroImage 2010; 49: 1133-43.
73. Schweinsburg AD, McQueeny T, Nagel BJ, Eyler LT, Tapert SF. A preliminary study of functional magnetic resonance imaging response during verbal encoding among adolescent binge drinkers. Alcohol 2010; 44: 111-7.
74. Jager G, Kahn RS, Van Den Brink W, Van Ree JM, Ramsey NF. Long-term effects of frequent cannabis use on working memory and attention: an fMRI study. Psychopharmacology 2006; 185: 358-68.
75. Jager G, Van Hell HH, De Win MM, et al. Effects of frequent cannabis use on hippocampal activity during an associative memory task. Eur Neuropsychopharmacol 2007; 17: 289-97.
76. Costa PT, McCrae RR. Normal personality assessment in clinical practice: The NEO personality inventory. Psychol Assessment 1992; 4: 5.
77. Menon V. Developmental cognitive neuroscience of arithmetic: implications for learning and education. ZDM: the international journal on mathematics education 2010; 42: 515-25.
78. Bunge SA, Wright SB. Neurodevelopmental changes in working memory and cognitive control. Curr Opin Neurobiol 2007; 17: 243-50.
79. Crone EA, Dahl RE. Understanding adolescence as a period of social-affective engagement and goal flexibility. Nat Rev Neurosci 2012; 13: 636-50.
80. Hirvonen J, Goodwin RS, Li CT, et al. Reversible and regionally selective downregulation of brain cannabinoid CB (1) receptors in chronic daily cannabis smokers. Mol Psychiatry 2012; 17: 642-9.
81. Medina KL, McQueeny T, Nagel BJ, Hanson KL, Yang TT, Tapert SF. Prefrontal cortex morphometry in abstinent adolescent marijuana users: subtle gender effects. Addict Biol 2009; 14: 457-68.
82. McQueeny T, Padula CB, Price J, Medina KL, Logan P, Tapert SF. Gender effects on amygdala morphometry in adolescent marijuana users. Behav Brain Res 2011; 224: 128-134.
83. Medina KL, Nagel BJ, Tapert SF. Abnormal cerebellar morphometry in abstinent adolescent marijuana users. Psychiatry Res 2010; 182: 152-9.
84. Lorenzetti V, Solowij N, Yücel M. The Role of Cannabinoids in Neuroanatomic Alterations in Cannabis Users. Biol Psychiatry 2015.
85. Kanayama G, Rogowska J, Pope H, Gruber SA, Yurgelun-Todd DA. Spatial working memory in heavy cannabis users: a functional magnetic resonance imaging study. Psychopharmacology 2004; 176: 239-47.
86. Becker B, Wagner D, Gouzoulis-Mayfrank E, Spuentrup E, Daumann J. Altered parahippocampal functioning in cannabis users is related to the frequency of use. Psychopharmacology 2010; 209: 361-74.
87. Smith AM, Longo CA, Fried PA, Hogan MJ, Cameron I. Effects of marijuana on visuospatial working memory: an fMRI study in young adults. Psychopharmacology 2010; 210: 429-38.
88. Bossong MG, Niesink RJ. Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabisinduced schizophrenia. Prog Neurobiol 2010; 92: 370-385.
89. Broyd SJ, van Hell HH, Beale C, Yücel M, Solowij N. Acute and chronic effects of cannabinoids on human cognition— A Systematic Review. Biological Psychiatry.
90. Vaidya CJ. Neurodevelopmental Abnormalities in ADHD. Curr Topics Behavioral Neurosci 2012; 9: 49-66.
91. Wood SJ, Pantelis C, Yung AR, Velakoulis D, McGorry PD. Brain changes during the onset of schizophrenia: implications for neurodevelopmental theories. Medical J Australia 2009; 190: S10.
92. Palmer R, Young S, Hopfer C, et al. Developmental epidemiology of drug use and abuse in adolescence and young adulthood: Evidence of generalized risk. Drug Alcohol Dependence 2009; 102: 78-87.
93. Butters JE. Family stressors and adolescent cannabis use: a pathway to problem use. J Adolescence 2002; 25: 645-54.
94. Giedd JN, Castellanos FX, Rajapakse JC, Vaituzis AC, Rapoport JL. Sexual dimorphism of the developing human brain. Prog Neuro-Psychopharmacol Biol Psychiatry 1997; 21: 1185-201.
95. Crowley TJ, Mikulich SK, MacDonald M, Young SE, Zerbe GO. Substance-dependent, conduct-disordered adolescent males: severity of diagnosis predicts 2-year outcome1. Drug Alcohol Dependence 1998; 49: 225-37.
96. Perkonigg A, Lieb R, Hofler M, Schuster P, Sonntag H, Wittchen H-U. Patterns of cannabis use, abuse and dependence over time: incidence, progression and stability in a sample of 1228 adolescents. Addiction 1999; 94: 1663-78.
97. Koob GF, Ahmed SH, Boutrel B, et al. Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci Biobehav Rev 2004; 27: 739-49.
98. Everitt BJ, Robbins TW. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nature Neurosci 2005; 8: 1481-1489.
99. Degenhardt L, Coffey C, Carlin JB, Swift W, Moore E, Patton GC. Outcomes of occasional cannabis use in adolescence: 10-year follow-up study in Victoria, Australia. Br J Psychiatry 2010; 196: 290-5.
100. Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. Bmj 2002; 325: 1212-3.
101. Di Forti M, Marconi A, Carra E, et al. Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study. The Lancet Psychiatry 2015; 2: 233-8.
102. Heim C, Nemeroff CB. The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol Psychiatry 2001; 49: 1023-39.
103. Kreek MJ, Nielsen DA, Butelman ER, LaForge KS. Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nat Neurosci 2005; 8: 1450-7.
104. Steinberg L. Risk taking in adolescence new perspectives from brain and behavioral science. Curr Directions Psychol Sci 2007; 16: 55-9.
105. Anokhin AP, Golosheykin S, Heath AC. Heritability of frontal brain function related to action monitoring. Psychophysiology 2008; 45: 524-34.
106. De Win MM, Jager G, Vervaeke HK, et al. The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance. Int J Methods Psychiatric Res 2005; 14: 167-85.